Titan Medical Inc. (Nasdaq: TMDI) designs and develops surgical technologies for robotic single access surgery, focuses on medical devices. TMDI shares plunged in the pre-market session as it was down -15.98% to $1.58 after the announcement that its board of directors has approved a deal under which Bloom Burton will purchase, on a bought deal basis, 6,451,613 shares of the Company for US$1.55 for aggregate gross proceeds of US$10,000,000.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
One unit consists of one common share in the company’s capital and one-half of a common share purchase warrant. Each Warrant is exercisable for one common share at an exercise price of US$2.00 per share for 60 months from the closing of the Offering.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Read More
Underwriters have been granted an option to purchase up to an additional 15% of the number of Units initially sold under the Offering at the Offering Price.
Proceeds from the Offering will develop the company’s robotic surgical technologies and general working capital. Under normal circumstances, the Offering is expected to close by January 29, 2021, or at another agreed-upon date by the Company and the Underwriters. These conditions are subject to the receipt of all necessary regulatory, stock market, and other approvals, including the Toronto Stock Exchange’s support.
